3-Bromopropylamine hydrobromide

Suppliers

Names

[ CAS No. ]:
5003-71-4

[ Name ]:
3-Bromopropylamine hydrobromide

[Synonym ]:
MFCD00012912
EINECS 225-675-0
3-Bromopropan-1-amine hydrobromide
3-bromopropan-1-amine,hydrobromide
3-Aminopropyl Bromide Hydrobromide

Chemical & Physical Properties

[ Boiling Point ]:
150.6ºC at 760 mmHg

[ Melting Point ]:
171-172 °C(lit.)

[ Molecular Formula ]:
C3H9Br2N

[ Molecular Weight ]:
218.918

[ Flash Point ]:
44.9ºC

[ Exact Mass ]:
216.910156

[ PSA ]:
26.02000

[ LogP ]:
2.38850

MSDS

Click to get detail MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
UH9925000
CHEMICAL NAME :
Propylamine, 3-bromo-, hydrobromide
CAS REGISTRY NUMBER :
5003-71-4
LAST UPDATED :
199712
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C3-H8-Br-N.Br-H
MOLECULAR WEIGHT :
218.95
WISWESSER LINE NOTATION :
Z3E &EH

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
109 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
YKKZAJ Yakugaku Zasshi. Journal of Pharmacy. (Nippon Yakugakkai, 2-12-15 Shibuya, Shibuya-ku, Tokyo 150, Japan) No.1- 1881- Volume(issue)/page/year: 97,1117,1977 ** TUMORIGENIC DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1150 mg/kg/8W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Lungs, Thorax, or Respiration - tumors
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year: 39,391,1979

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H315-H319-H335

[ Precautionary Statements ]:
P261-P305 + P351 + P338

[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Gloves

[ Hazard Codes ]:
Xi:Irritant;

[ Risk Phrases ]:
R36/37/38

[ Safety Phrases ]:
S26-S36-S37/39

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

[ RTECS ]:
UH9925000

[ HS Code ]:
2921199090

Precursor & DownStream

Precursor

  • 3-Aminopropan-1-ol

DownStream

  • 2H-1,3-Thiazine-2-thione,tetrahydro-
  • Azetidine
  • Benzyl (3-bromopropyl)carbamate
  • phenylthiopropylamine
  • 3-Bromopropylamine
  • 3,4-dihydro-2H-pyrimido[1,2-b]isoindol-6-one
  • BENZYL-(5,6-DIHYDRO-4H-[1,3]THIAZIN-2-YL)-AMINE
  • 3-(4-Phenylpiperazin-1-yl)propan-1-amine
  • tert-Butyl 3-bromopropylcarbamate

Customs

[ HS Code ]: 2921199090

[ Summary ]:
2921199090 other acyclic monoamines and their derivatives; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0%

Articles

Direct Pore Binding as a Mechanism for Isoflurane Inhibition of the Pentameric Ligand-gated Ion Channel ELIC.

Sci. Rep. 5 , 13833, (2015)

Pentameric ligand-gated ion channels (pLGICs) are targets of general anesthetics, but molecular mechanisms underlying anesthetic action remain debatable. We found that ELIC, a pLGIC from Erwinia chrys...

Inhibition of tissue-bound semicarbazide-sensitive amine oxidase by two haloamines, 2-bromoethylamine and 3-bromopropylamine.

Arch. Biochem. Biophys. 385(1) , 154-61, (2001)

Various mammalian tissues contain membrane-bound amine oxidase termed semicarbazide-sensitive amine oxidase (SSAO). A variety of compounds has been identified as relatively selective SSAO inhibitors, ...

Modification of cysteine.

Curr. Protoc. Protein Sci. Chapter 15 , Unit15.1, (2001)

This unit describes a number of methods for modifying cysteine residues of proteins and peptides by reduction and alkylation procedures. A general procedure for alkylation of cysteine residues in a pr...


More Articles

Related Compounds

  • 3-bromopropylamine hydrobromide
  • 2-Bromopropan-1-amine hydrobromide
  • N-(benzylidene)-3-bromopropylamine
  • 2-bromo-N,N-dimethylpropan-1-amine,hydrobromide
  • Benzyl (3-bromopropyl)carbamate
  • Benzenemethanamine,N-(3-bromopropyl)-a,a-diphenyl-
  • 1-(5-bromo-3-fluoropyridin-2-yl)-4-{[3-(difluoromethyl)-1-methyl-1H-pyrazol-4-yl]methyl}piperazine
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
  • tert-Butyl-DL-alanine
  • 2-{1-[({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)methyl]cyclopropaneamido}-5-hydroxybenzoic acid